Latest posts
-
AI in Pharma Market Access: Mid-2025 Update
Six months on from our 2025 outlook, AI has moved from pilot to production in market access. Investors are backing AI-enabled solutions, payers are scaling AI for member support and prior auth, regulators are enforcing the EU AI Act, and CMS is updating PE methodology. Here’s what changed and what PMA teams should do next.
-
Will AI Revolutionize Market Access and Pricing? Trends for 2025
AI in Pharmaceutical Market Access Key Trends and Implementation Strategies for 2025 Read Article AI Revolutionizes Pharmaceutical Market Access and Pricing The pharmaceutical industry is experiencing a seismic shift as artificial intelligence transforms market access and pricing strategies. With the AI pharma market projected to skyrocket from $1.94 billion in 2025 to $16.49 billion by…